期刊文献+

洛铂、草酸铂分别联合替加氟持续泵入治疗晚期胃癌的比较研究 被引量:11

Comparative study of lobaplatin or oxaliplatin combined with tegafur in the treatment of advanced gastric cancer
下载PDF
导出
摘要 目的:探讨洛铂、草酸铂分别联合替加氟持续泵入治疗晚期胃癌的效果。方法:64例晚期胃癌患者分别接受方案A(32例)、方案B(32例)治疗。方案A:替加氟800mg/m2,CIV(24h),d1-5;LV200mg/m2,ivgtt(2h),d1-5;L-OHP135mg/m2,ivgtt(2h),d1。方案B:替加氟800mg/m2,CIV(24h),d1-5,LV200mg/m2,ivgtt(2h),d1-5;LBP35mg/m2,ivgtt,d1。28天为1周期。结果:方案A:CR5例,PR16例,有效率65.6%;方案B:CR7例,PR16例,有效率71.9%;方案B优于方案A,但差异无显著性意义(P=0.849)。两种方案的不良反应均易于接受。结论:替加氟分别与洛铂、草酸铂联合可以作为晚期胃癌安全有效的治疗方案。 Objective:To study the effect of lobaplatin or oxaliplatin combined with tegafur in the treatment of advanced gastric cancer. Methods : Total of 64 cases of advanced gastric cancer were treated with regimenA, regimenB. Regimen A : tegafur 800mg/m^2, CIV ( 24h ), d1 - 5 ; LV20Omg/m^2, ivgtt ( 2h ), d1 -5 ; L - OHP135 mg/m^2, ivgtt ( 2h ), d1. RegimenB : tegafur 800mg/m^2, CIV ( 24h ), d1-5, LV20Omg/m^2, ivgtt ( 2h ) , d1 -5 ; LBP35mg/m^2, ivgtt, d1. Regimen A and B were repeated every 28 days. Results:There were 5 CR,16 cases in the regimen A; 4 CR,16 PR cases in the regimen B ;effective rates were 65.6% and 71.9% respectively ( P = 0. 849). The adverse effects of the 2 regimens were mild. Conclusion:Lobaplatin or oxaliplatin combined with tegafur in the treatment of advanced gastric cancer is safe and effective.
出处 《现代肿瘤医学》 CAS 2008年第10期1743-1744,共2页 Journal of Modern Oncology
关键词 胃癌 辅助化疗 洛铂 草酸铂 替加氟 gastric carcinoma chemotherapy lobaplatin oxaliplatin tegafur
  • 相关文献

参考文献6

  • 1李连弟,饶克勤,张思维,鲁凤珠,邹小农.中国12市县1993年~1997年肿瘤发病和死亡登记资料统计分析[J].中国肿瘤,2002,11(9):497-507. 被引量:193
  • 2Ppllock RE.临床肿瘤学手册[M].长春:吉林科学技术出版社,2000.477~478.
  • 3吴萍,王理伟,周翡,刘全珍.含草酸铂和含表阿霉素联合方案治疗晚期胃癌的临床观察[J].中华肿瘤防治杂志,2006,13(1):58-60. 被引量:18
  • 4Jamieson ER, Lippard SJ. Structure, recognition, and processing of cisplatin - DNA adducts [ J ]. Chem Rev, 1999,99 ( 9 ) : 2467 - 2498.
  • 5Saris CP, Van De VP, Rietbroek RC, et al. In vitro formation of DNA adducts by cisplatin,lobaplatin and oxaliplatin in calf thymus DNA in solution and in cultured human cells [J]. Carcinogenesis, 1966,17 (12) :2763 - 2769.
  • 6Fiebig HH, Henb H, Vonpawel I, et al. Phase Ⅱ clinical trial of lobaplatin ( D - 19466 ) in pretreated patients with small - cell lung cancer [ J ]. Onkologie, 1996,19 : 328 - 332.

二级参考文献9

共引文献207

同被引文献79

引证文献11

二级引证文献156

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部